Usage Information

Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.
R Evers, … , P Borst, A H Schinkel
R Evers, … , P Borst, A H Schinkel
Published March 1, 1996
Citation Information: J Clin Invest. 1996;97(5):1211-1218. https://doi.org/10.1172/JCI118535.
View: Text | PDF
Research Article

Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.

Abstract

The human multidrug resistance-associated protein MRP confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Recent evidence indicates that MRP can also transport glutathione S-conjugates across membranes. To study the transport properties of MRP in intact cells, we have expressed human MRP cDNA in the polarized pig kidney epithelial cell line LLC-PK1. MRP mainly localized to the basolateral plasma membrane of these cells, and not to the apical membrane, as determined by immunocytochemistry using confocal laser scanning and electron microscopy. In accordance with this localization, MRP caused increased transport of the glutathione S-conjugate S-(2, 4-dinitrophenyl)-glutathione and of the anticancer drug daunorubicin to the basal side of the epithelial cell layer. Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport, inhibited this basolateral transport, but not the apical transport of daunorubicin mediated by the apically localized human MDR1 P-glycoprotein in MDR1-transfected LLC-PK1 cells. Probenecid and sulfinpyrazone may therefore be useful lead compounds for the development of clinical reversal agents specific for MRP-mediated drug resistance.

Authors

R Evers, G J Zaman, L van Deemter, H Jansen, J Calafat, L C Oomen, R P Oude Elferink, P Borst, A H Schinkel

×

Usage data is cumulative from January 2024 through January 2025.

Usage JCI PMC
Text version 178 24
PDF 49 42
Citation downloads 44 0
Totals 271 66
Total Views 337
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement